Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study

Table 2

Preoperative variables.

Indication	n (%) or median (IQR)
Thrombus	6 (35.3)
Septic thrombus	1 (5.9)
Endocarditis	10 (58.8)
Bacterial cultures
Methicillin-sensitive Staph. aureus	5 (29.4)
Methicillin-resistance Staph. aureus	3 (17.6)
Staph. epidermidis	1 (5.9)
E. faecalis	1 (5.9)
Polymicrobial	2
Location
SVC	1 (5.9)
IVC/RA	2 (11.8)
RA	5 (29.4)
TV	8 (47.1)
Average size	3.48 (2.25–4.7)
Mobility
Mobile	11 (64.7)
Immobile	2 (11.8)
LVEF	51.9 (42–60)
Hemoglobin	9.1 (7.8–10.7)
Creatinine	1.12 (0.67–0.98)

^∗Cultures include MRSA/Strep. gordonii and Enterobacter/Klebsiella/Citrobacter/Bacteroides. ^∗∗Multiple locations documented. IQR: interquartile range; IVC: inferior vena cava; LVEF: left ventricular ejection fraction; MRSA: methicillin-resistant Staphylococcus aureus; RA: right atrium; Staph: Staphylococcus; Strep: Streptococci; SVC: superior vena cava; TV: tricuspid valve.